Yanis Boumber, MD, PhD, has opened the first of ten new lung cancer clinical trials. Called Neptune, the phase 3 clinical trial combines two new immunotherapy drugs. Dr. Boumber talks to Mike Jaxson, KSVP-FM, about the trial:

Read the press release and the story in the Roswell Daily Record. And, view Dr. Boumber's interview on "KRQE This Morning" with Adam Atchison:

Tags: advanced lung cancer, clinical trial, In the News Archive, Lung Cancer, unmccc